Market revenue in 2023 | USD 40.4 million |
Market revenue in 2030 | USD 107.3 million |
Growth rate | 15% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 53.96% in 2023. Horizon Databook has segmented the Canada next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
Canada NGS data analysis market is expected to grow at a significant rate with a number of provincial and national initiatives undertaken for NGS-based research. For instance, Exactis Innovation, a nonprofit, pan-Canadian organization, offers accelerated access to clinical trials for personalized medicine, especially for cancer.
The Personalize My Treatment program of Exactis focuses on the selection of patients suitable for clinical trials based on sequencing studies. Such initiatives drive the demand for NGS-based software in these clinical trials in Canada. Furthermore, several initiatives are being undertaken by key players, such as Qiagen, Illumina, Roche, and Thermo Fisher Scientific, Inc., present in the country.
Government agencies are also involved in such activities to broaden the landscape of NGS technologies in Canada, which further drives market growth. For instance, in July 2019, the Ontario Institute for Cancer Research, Genome Canada, and Thermo Fisher Scientific, Inc. collaborated for the development of a complete solution of targeted NGS assays & analysis software.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into Canada next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account